February 28, 2022
Life Sciences
  • Two small biotech companies sued Moderna Inc. on claims that it infringed on their patent rights for a technology they said was key to Moderna developing its mRNA vaccine for COVID-19. Moderna has said it expects vaccine sales to top $19 billion in 2022.The two biotechs, Arbutus Biopharma Corp. and Genevant Sciences Corp., could demand royalties from Moderna’s shot if their lawsuit succeeds. (Article here)